CAPSULAR WARNING SYNDROME

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting CAPSULAR WARNING SYNDROME:

# Drug Count
0 ASPIRIN 5
1 ASPIRIN 325 MG 5
2 ASPIRIN 81 MG 5
3 CLOPIDOGREL 5
4 CLOPIDOGREL BISULFATE 5
5 TIROFIBAN 4
6 ALTEPLASE 3
7 APIXABAN 2
8 NIFEDIPINE 1
See all common drugs associated with CAPSULAR WARNING SYNDROME

CAPSULAR WARNING SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TIROFIBAN 4 0.0014
1 ALTEPLASE 3 0.0002
2 CLOPIDOGREL BISULFATE 5 0.0000
3 APIXABAN 2 0.0000
4 CLOPIDOGREL 5 0.0000
5 NIFEDIPINE 1 0.0000
6 ASPIRIN 5 0.0000
See all drugs enriched for association with CAPSULAR WARNING SYNDROME

CAPSULAR WARNING SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 P2Y12 Platelet Inhibitor [EPC] 5 0.0000
1 Platelet Aggregation Inhibitor [EPC] 5 0.0000
2 Factor Xa Inhibitor [EPC] 2 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
4 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
See all drug classes enriched for association with CAPSULAR WARNING SYNDROME